Mi2000 Totally Implantable Cochlear Implant (Mi2000 TICI)

Last updated: March 7, 2025
Sponsor: MED-EL Elektromedizinische Geräte GesmbH
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Hearing Loss

Deafness

Hearing Impairment

Treatment

Mi2000 TICI

Clinical Study ID

NCT06459765
MED-EL_CRD_2021_02
  • Ages > 18
  • All Genders

Study Summary

The goal of this clinical trial is to test the Mi2000 Totally Implantable Cochlear Implant in a population of candidates for a cochlear implant. The main question it aims to answer is, whether the device is able to improve speech perception compared to the pre-operative score.

Participants will undergo cochlear implantation and fitting, and will be asked to perform the following tests pre- and post-operatively:

  • Word test in quiet

  • Sentence test in noise

  • Audiograms

  • Health Utilities Index 2 and 3 (HUI2&3), a generic quality-of-life questionnaire

  • Nijmengen Cochlear Implant Questionnaire (NCIQ), a disease specific quality-of life questionnaire

  • Speech, Spatial and Qualities of Hearing Scale (SSQ12), a disease specific questionnaire

  • Hearing Implant Sound Quality Index (HISQUI19), a sound quality questionnaire

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Minimum age of eighteen (18) years at time of enrolment

  • Bilateral sensorineural hearing loss with no or limited benefit from a hearing aid (>70 dB HL PTA4)

  • Post-lingual onset of deafness

  • No or limited benefit from hearing aids for less than 10 years and an expectedbenefit from cochlear implantation

  • A maximum score of 50% on a word test in the language of the test centre in the earto be implanted in the best aided condition

  • Fluency in the test language with excellent proficiency, as appropriate to performspeech testing

  • Functional auditory nerve

  • General health condition, psychological and emotional condition deemed compatiblewith the treatment and tests performed in this study

  • Pre-operative assessment according to the local professional standards

  • Candidate is highly motivated and has realistic expectations about the expectedbenefit of the implant and shall understand the importance of returning to theimplant centre for regular speech processor programming, assessment sessions andtraining

  • Realistic expectations, as deemed appropriate by the implanting surgeon/implantboard

  • Evidence of up-to-date vaccinations against meningitis, as per recommendations bythe applicable national body

  • Signed and dated informed consent before the start of any study-specific procedure

Exclusion

Exclusion Criteria:

  • Lack of compliance with any inclusion criterion

  • Previously having received an implant on the location chosen for placing thecochlear implant

  • Having received a hearing implant from another manufacturer than MED-EL on thecontralateral ear

  • Pre-existing condition known to necessitate MRI scans after implantation of theMi2000 TICI

  • Women being pregnant or nursing

  • Women of childbearing age not reporting to use effective contraception

  • The individual is known to be intolerant of the materials used in the implant orother required accessories including medical grade silicone, parylene C, titanium,platinum iridium, platinum, stainless chromate steel, thermoplastic elastomere (TPE-S), thermoplastic elastomere (SEBS), mixture of polycarbonate andacrylonitrile-butadiene-styrol polymer (PC/ABS), polyamide, liquid crystal polymer,silicone and polyurethane-coated silicone rubber)

  • Absence of cochlear development

  • The cause of deafness is non-functionality of the auditory nerve and/or the upperauditory pathway

  • Medical contra-indications to middle ear and/or inner ear surgery, and/oranaesthesia

  • External or middle ear infections are present

  • The tympanic membrane is perforated in the ear to be implanted

  • Anatomic abnormalities are present that would prevent appropriate placement of thestimulator housing in the bone of the skull, or prevent placement of the chosenelectrode array into the cochlea (including ossification of the cochlea)

  • The psychological status of the individual is unstable

  • The individual has unrealistic expectations

  • Acute cholesteatoma

  • History of vestibular schwannoma

  • Unstable Meniere's disease

  • Auditory Neuropathy

  • Epilepsy not responding to treatment

  • Permanent inability and/or unwillingness to participation in post-operative care andrehabilitation

  • Known intellectual disability and/or psychological diseases

  • Participation in other pharmacological clinical trials within four weeks prior toenrolment

  • Anything that, in the opinion of the Investigator, would place the subject atincreased risk; preclude the subject's full compliance with or completion of thestudy

Study Design

Total Participants: 30
Treatment Group(s): 1
Primary Treatment: Mi2000 TICI
Phase:
Study Start date:
June 07, 2024
Estimated Completion Date:
October 31, 2025

Study Description

Cochlear implants (CI) provide a large majority of recipients with a significant degree of speech understanding. However, CI systems rely on external audio processors to function. This can have several disadvantages: for instance, the hardware is exposed to external trauma and to the effects of head movement and gravity. The device is also put at risk by humid, dusty, or dirty conditions as well as by physical activities that lead to water exposure such as swimming or sports in general (e.g. perspiration).

In addition, some patients are concerned with the cosmetic appearance of the external parts which are visible (more so than modern behind-the-ear hearing aids), something that may not be desirable to many potential candidates.

This clinical investigation aims to collect confirmatory data on the use of the Mi2000 Totally Implantable Cochlear Implant system used in combination with compatible devices.

Connect with a study center

  • AKH Wien

    Wien, 1090
    Austria

    Site Not Available

  • UZA Antwerpen

    Antwerp, 2650
    Belgium

    Site Not Available

  • CHU Liège

    Liège, 4000
    Belgium

    Site Not Available

  • LMU Munich

    München, Bavaria 81377
    Germany

    Site Not Available

  • UKW Würzburg

    Würzburg, Bavaria 97080
    Germany

    Site Not Available

  • The Institute of Physiology and Pathology of Hearing

    Nadarzyn, 05-830
    Poland

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.